Scientific contributions
NeoGenomics is committed to the advancement of cancer care. We work with institutions and thought leaders to continually innovate and develop more impactful diagnostic, therapy selection, and MRD tests.
Trusted CGP results for myeloid disorders now in 8-11 days Learn more
Trusted CGP results for heme cancers now in 8-11 days Learn more
NeoGenomics is committed to the advancement of cancer care. We work with institutions and thought leaders to continually innovate and develop more impactful diagnostic, therapy selection, and MRD tests.